Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from rmo Fisher

Family of Henrietta Lacks asks court to reject Thermo Fisher’s second motion to dismiss lawsuit

BALTIMORE — Family members of Henrietta Lacks are asking a federal judge to reject Thermo Fisher Scientific’s second attempt to get the court to dismiss the family’s lawsuit against the multimillion-dollar biotech company.

Tribune News Service

Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report

Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report

Thermo Fisher easily beat quarterly projections, while Boston Scientific was in line. TMO stock popped Wednesday while BSX stock also rose.

Investors Business Daily

Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Court to consider whether Henrietta Lacks’ family’s ‘unprecedented’ lawsuit over use of her cells can continue

BALTIMORE — A federal judge will decide whether the family of Henrietta Lacks has enough legal standing to continue its lawsuit against the biotech company Thermo Fisher Scientific after the two sides argued in court Tuesday about the use of cells taken from Lacks more than 70 years ago.

Tribune News Service

Thermo Fisher opens R&D facility in Hyderabad

IEC plans to invest $15 million annually

Thermo Fisher Scientific Stock Jumps As Q1 Earnings Surpass Consensus

Thermo Fisher Scientific Inc (NYSE:TMO) has posted Q1 revenue of $11.82 billion, beating the consensus of $10.63 billion. Organic revenue growth was 3%, acquisitions increased revenue by 18%, and currency translation decreased revenue by 2%. Core organic growth was 16%. COVID-19 testing revenue was $1.68 billion. Revenue from Life Sciences Solutions Segment…

Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others

As supply chain constraints continue to squeeze health care stocks, one analyst suggested Monday to look for "ports in storms."

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Inc (NASDAQ:MRNA) reports a Q4 EPS of $11.29, a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9…

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna Inc (NASDAQ: MRNA) has en

People

139,553 stories

Henrietta Lacks

Deborah Boardman

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intuitive Surgical

Boston Scientific

Board of Directors

rmo Fisher Scientific

Becton Dickinson

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play